Companies/US/CMMB

CHEMOMAB THERAPEUTICS LTD.

Last · NasdaqCM$1.29+0.05 (+4.03%)close · yahoo · 17h ago
Vol 25.8K ≈ 33.3K
Market cap$9.45M7.3M sh
P/E · TTM-1.2fwd -43.0 · eps -1.07 · loss
Beta0.74vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.051$3.49
Volume25.8Ksession

Issuer

Legal nameCHEMOMAB THERAPEUTICS LTD.
HQUnited States (US)
ListingUS CMMB
ISINUS16385C2035
LEI894500LSC3H1WGG6LV25
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001534248
CIK0001534248
Websitewww.chemomab.com
LinkedIn
Employees3
AddressChemomab Therapeutics Ltd. Kiryat Atidim 6158002, Tel Aviv +972 77 331 0156
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

  • GlobeNewswire

    Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

Documents

FormReporting forFiledFlags
6-K
—2026-09-300
4
2026-08-272026-09-010
6-K
2026-06-302026-08-190
6-K
2026-07-082026-07-080
6-K
2026-06-022026-06-020
Showing 5 of 44 filings